CCL20 and myeloid sarcoma: CCR6+ expressing cells showed similar distribution as CCL20+ ones (Fig. 4), with the CC group presenting lower expressing-cell frequency when compared to the HC in IE (p < 0.05) and MS areas (p < 0.001), and with CIN I only in MS areas (p < 0.001).